{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T20:18:32Z","timestamp":1765484312350,"version":"build-2065373602"},"reference-count":31,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Medical Sciences"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.advms.2022.07.005","type":"journal-article","created":{"date-parts":[[2022,8,19]],"date-time":"2022-08-19T13:20:54Z","timestamp":1660915254000},"page":"298-303","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["The relationship between Vaspin, Nesfatin-1 plasma levels and presence of fragmented QRS with the severity of coronary atherosclerosis"],"prefix":"10.1016","volume":"67","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8484-4689","authenticated-orcid":false,"given":"Berna","family":"Stavileci","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zehra Lale","family":"Kolda\u015f","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2008","series-title":"Risk factors for coronary artery disease. Braunwald's heart disease: a textbook of cardiovascular medicine","author":"Ridker","key":"10.1016\/j.advms.2022.07.005_bib1"},{"key":"10.1016\/j.advms.2022.07.005_bib2","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.peptides.2013.06.006","article-title":"Decreased plasma Nesfatin-1 levels in patients with acute myocardial infarction","volume":"46","author":"Dai","year":"2013","journal-title":"Peptides"},{"key":"10.1016\/j.advms.2022.07.005_bib3","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1507\/endocrj.K11E-056","article-title":"Nesfatin-1 enhances glucoseinduced insulin secretion by promoting Ca(2+) influx through L-type channels in mouse islet \u03b2-cells","volume":"58","author":"Nakata","year":"2011","journal-title":"Endocr J"},{"key":"10.1016\/j.advms.2022.07.005_bib4","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1111\/j.1365-2826.2012.02304.x","article-title":"Evidence for a role of endogenous Nesfatin-1 in the control of water drinking","volume":"24","author":"Yosten","year":"2012","journal-title":"J\u00a0Neuroendocrinol"},{"key":"10.1016\/j.advms.2022.07.005_bib5","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/90992","article-title":"The adipocyte-secreted protein Acrp30 enhances hepatic insulin action","volume":"7","author":"Berg","year":"2001","journal-title":"Nat Med"},{"issue":"3","key":"10.1016\/j.advms.2022.07.005_bib6","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/S0002-9149(83)80105-2","article-title":"A\u00a0more meaningful scoring system for determining the severity of coronary heart disease","volume":"51","author":"Gensini","year":"1983","journal-title":"Am J Cardiol"},{"issue":"113","key":"10.1016\/j.advms.2022.07.005_bib7","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1161\/CIRCULATIONAHA.105.595892","article-title":"Significance of a fragmented QRS complex versus a Q wave in patients with coronary artery disease","volume":"30","author":"Das","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.advms.2022.07.005_bib8","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1210\/jcem.86.5.7463","article-title":"Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia","volume":"86","author":"Weyer","year":"2001","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.advms.2022.07.005_bib9","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.cca.2010.09.012","article-title":"Serum levels of Vaspin and visfatin in patients with coronary artery disease-Kozani study","volume":"412","author":"Kadoglou","year":"2011","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.advms.2022.07.005_bib10","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1016\/j.clinbiochem.2013.06.028","article-title":"Plasma Vaspin concentrations are decreased in acute coronary syndrome, but unchanged in patients without coronary lesions","volume":"46","author":"Zhang","year":"2013","journal-title":"Clin Biochem"},{"key":"10.1016\/j.advms.2022.07.005_bib11","first-page":"110","article-title":"The investigation of serum Vaspin level in atherosclerotic coronary artery disease","volume":"4","author":"Kobat","year":"2012","journal-title":"J\u00a0Clin Med Res"},{"key":"10.1016\/j.advms.2022.07.005_bib12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0052346","article-title":"Vaspin increases nitric oxide bioavailability through the reduction of asymmetric dimethylarginine in vascular endothelial cells","volume":"7","author":"Jung","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.advms.2022.07.005_bib13","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.atherosclerosis.2013.02.013","article-title":"Vaspin attenuates high glucose-induced vascular smooth muscle cells proliferation and chemokinesis by inhibiting the MAPK, PI3K\/Akt, and NF-\u03baB signaling pathways","volume":"228","author":"Li","year":"2013","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.advms.2022.07.005_bib14","first-page":"482","article-title":"Vaspin alleviates dysfunction of endothelial progenitor cells induced by high glucose via PI3K\/Akt\/eNOS pathway","volume":"8","author":"Sun","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1016\/j.advms.2022.07.005_bib15","doi-asserted-by":"crossref","first-page":"372","DOI":"10.2337\/db07-1045","article-title":"Serum Vaspin concentrations in human obesity and type 2 diabetes","volume":"57","author":"Youn","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.advms.2022.07.005_bib16","doi-asserted-by":"crossref","first-page":"10610","DOI":"10.1073\/pnas.0504703102","article-title":"Visceral adipose tissue-derived serine protease inhibitor: a unique insulin-sensitizing adipocytokine in obesity","volume":"102","author":"Hida","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.advms.2022.07.005_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0094763","article-title":"Role of serum Vaspin in progression of type 2 diabetes: a 2-year cohort study","volume":"9","author":"Jian","year":"2014","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.advms.2022.07.005_bib18","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1248\/bpb.34.307","article-title":"Vascular effects of novel adipocytokines: focus on vascular contractility and inflammatory responses","volume":"34","author":"Yamawaki","year":"2011","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.advms.2022.07.005_bib19","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/128014","article-title":"Decreased plasma Nesfatin-1 level is related to the thyroid dysfunction in patients with type 2 diabetes mellitus","author":"Liu","year":"2014","journal-title":"J\u00a0Diabetes Res"},{"key":"10.1016\/j.advms.2022.07.005_bib20","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s00441-011-1268-5","article-title":"Nesfatin-1 stimulates glucagon and insulin secretion and beta cell NUCB2 is reduced in human type 2 diabetic subjects","volume":"346","author":"Riva","year":"2011","journal-title":"Cell Tissue Res"},{"key":"10.1016\/j.advms.2022.07.005_bib21","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1055\/s-0031-1286339","article-title":"Increased plasma levels of Nesfatin1 in patients with newly diagnosed type 2 diabetes mellitus","volume":"120","author":"Zhang","year":"2012","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/j.advms.2022.07.005_bib22","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.regpep.2011.05.008","article-title":"Imp act of atorvastatin on serum Vaspin levels in hypercholesterolemic patients with moderate cardiovascular risk","volume":"170","author":"Kadoglou","year":"2011","journal-title":"Regul Pept"},{"key":"10.1016\/j.advms.2022.07.005_bib23","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.mce.2015.09.006","article-title":"AMPK-dependent modulation of hepatic lipid metabolism by Nesfatin-1","volume":"417","author":"Yin","year":"2015","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.advms.2022.07.005_bib24","doi-asserted-by":"crossref","first-page":"402","DOI":"10.3109\/1354750X.2014.919027","article-title":"Decreased levels of serum Nesfatin-1 in patients with preeclampsia","volume":"19","author":"Zhang","year":"2014","journal-title":"Biomarkers"},{"key":"10.1016\/j.advms.2022.07.005_bib25","first-page":"189","article-title":"The relation of serum Nesfatin-1 level with metabolic and clinical parameters in obese and healthy children","volume":"14","author":"Abaci","year":"2013","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/j.advms.2022.07.005_bib26","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3109\/10641963.2014.897722","article-title":"Nesfatin-1 correlates with hypertension in overweight or obese Han Chinese population","volume":"37","author":"Zhao","year":"2015","journal-title":"Clin Exp Hypertens"},{"key":"10.1016\/j.advms.2022.07.005_bib27","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1152\/ajpregu.00804.2009","article-title":"The anorexigenic and hypertensive effects of nesfatin-1 are reversed by pretreatment with an oxytocin receptor antagonist","volume":"298","author":"Yosten","year":"2010","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"2","key":"10.1016\/j.advms.2022.07.005_bib28","article-title":"Serum vaspin as a predictor of adverse cardiac events in acute myocardial infarction","volume":"8","author":"Zhou","year":"2019","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.advms.2022.07.005_bib29","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jcmg.2010.10.008","article-title":"Left ventricular remodeling in heart failure: current concepts in clinical significance and assessment","volume":"4","author":"Konstam","year":"2011","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.advms.2022.07.005_bib30","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nrcardio.2014.28","article-title":"The inflammatory response in myocardial injury, repair, and remodelling","volume":"11","author":"Frangogiannis","year":"2014","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.advms.2022.07.005_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2022.155848","article-title":"Prognostic role of inflammatory cytokines and novel adipokines in acute myocardial infarction: an updated and comprehensive review","volume":"153","author":"Mitsis","year":"2022","journal-title":"Cytokine"}],"container-title":["Advances in Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1896112622000293?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1896112622000293?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T11:41:13Z","timestamp":1761824473000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1896112622000293"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["S1896112622000293"],"URL":"https:\/\/doi.org\/10.1016\/j.advms.2022.07.005","relation":{},"ISSN":["1896-1126"],"issn-type":[{"type":"print","value":"1896-1126"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The relationship between Vaspin, Nesfatin-1 plasma levels and presence of fragmented QRS with the severity of coronary atherosclerosis","name":"articletitle","label":"Article Title"},{"value":"Advances in Medical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.advms.2022.07.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Medical University of Bialystok. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}